RESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS

Similar documents
QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients

Peggy Leslie-Smith, RN

The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers

JCM Version 3. Utilization of the QuantiFERON-TB Gold Test in a 2-Step Process with the

Adachi et al. SpringerPlus 2013, 2:440 a SpringerOpen Journal

Journal of Infectious Diseases Advance Access published August 2, 2013

Literature Overview. Health Economics. Experience with QuantiFERON -TB Gold. Cellestis Clinical Guide series

Effect of prolonged incubation time on the results of the QuantiFERON TB Gold In-Tube assay for the diagnosis of latent tuberculosis infection

Approaches to LTBI Diagnosis

TB Prevention Who and How to Screen

Detecting latent tuberculosis using interferon gamma release assays (IGRA)

Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia

TB Intensive San Antonio, Texas November 11 14, 2014

RISK FACTORS FOR LATENT TUBERCULOSIS INFECTION AMONG HEALTH-CARE WORKERS IN NORTHEASTERN THAILAND

Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-c release assay

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB Intensive Houston, Texas October 15-17, 2013

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014

The Prevalence and Risk Factors of Latent Tuberculosis Infection among Health Care Workers Working in a Tertiary Hospital in South Korea

Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment

Time interval to conversion of interferon-c release assay after exposure to tuberculosis

2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016

TB Intensive Tyler, Texas December 2-4, 2008

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Occupational Risk of Latent Tuberculosis Infection in Health Workers of 14 Military Hospitals

ORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients

Performance of QuantiFERON-TB Gold and Tuberculin Skin Test Relative to Subjects Risk of Exposure to Tuberculosis

Clinical Policy Title: Interferon-gamma release assays for tuberculosis screening

Diagnosis and Treatment of Latent Tuberculosis Infection in Healthcare Workers

These recommendations will remain in effect until the national shortage of PPD solution has abated.

The Prevalence Rate of Tuberculin Skin Test Positive by Contacts Group to Predict the Development of Active Tuberculosis After School Outbreaks

An evaluation of the QuantiFERONÂ Gold tuberculosis-screening test for employees at the Portland Veterans Affairs Medical Center

Use of Interferon-γ Release Assays (IGRAs) in TB control in low and middle-income settings - EXPERT GROUP MEETING -

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Technical Bulletin No. 172

Albert Nienhaus 1,2* and José Torres Costa 3

Incidence of occupational latent tuberculosis infection in South African healthcare workers

Interpretation of TST & IGRA results. Objectives

Diagnosis Latent Tuberculosis. Disclosures. Case

*Bamrasnaradura Infectious Diseases Institute, Nonthaburi 11000, Bangkok Hospital, Bangkok, Thailand. ABSTRACT

Is the QuantiFERON-TB Blood Assay a Good Replacement for the Tuberculin Skin Test in Tuberculosis Screening? A Pilot Study at Berkshire Medical Center

T-CELL RESPONSES ASSESSED USING IGRA AND TST ARE NOT CORRELATED WITH AFB GRADE AND CHEST RADIOGRAPH IN PULMONARY TUBERCULOSIS PATIENTS

Identifying TB co-infection : new approaches?

Coordinating with Public Health on Tuberculosis Testing & Treatment

Investigation of false-positive results by the QuantiFERON-TB Gold In-Tube assay

Factors Associated with Indeterminate and False Negative Results of QuantiFERON-TB Gold In-Tube Test in Active Tuberculosis

Analysis of an Interferon-Gamma Release Assay for Monitoring the Efficacy of Anti-Tuberculosis Chemotherapy

Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients

Prevalence of Latent Tuberculosis Infection among Health Care Workers in South Korea: A Multicenter Study

KJLM. Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents

Comparison of Quantiferon-TB Gold With Tuberculin Skin Test for Detecting Latent Tuberculosis Infection Prior to Liver Transplantation

Testing for TB. Bart Van Berckelaer Territory Manager Benelux. Subtitle

Clinical Policy Title: Interferon-gamma release assays for tuberculosis screening

Richard N. van Zyl-Smit 1, Rannakoe J. Lehloenya 1,2, Richard Meldau 1, Keertan Dheda 1,3,4. Introduction

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review

Update on IGRA Predictive Value

T-Cell Assays for Tuberculosis Infection: Deriving Cut- Offs for Conversions Using Reproducibility Data

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines

Diagnosis and Medical Case Management of Latent TB. Bryan Rock, MD April 27, 2010

Tuberculin Skin Test (TST) and Interferon-gamma Release Assays (IGRA)

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

2017/2018 Annual Volunteer Tuberculosis Notice

Within-Subject Variability of Mycobacterium tuberculosis-specific Gamma Interferon Responses in German Health Care Workers

QuantiFERON-TB Gold and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Children

Dimitrios Vassilopoulos,* Stamatoula Tsikrika, Chrisoula Hatzara, Varvara Podia, Anna Kandili, Nikolaos Stamoulis, and Emilia Hadziyannis

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University

The Role of the Interferon Gamma Release Assay in Assessing Recent Tuberculosis Transmission in a Hospital Incident

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

A Clinician s Perspective: Improving Rheumatology Patient Care Using the T-SPOT.TB Test

CHAPTER 3: DEFINITION OF TERMS

TB in Corrections Phoenix, Arizona

Mædica - a Journal of Clinical Medicine

Author's response to reviews

Predictive Value of interferon-gamma release assays for incident active TB disease: A systematic review

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Use of an Interferon- Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients*

Rates of Latent Tuberculosis in Health Care Staff in Russia

Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast

ATTACHMENT 2. New Jersey Department of Health Tuberculosis Program FREQUENTLY ASKED QUESTIONS

Interferon-Gamma Release Assays and Pediatric Public Health Tuberculosis Screening: The San Francisco Program Experience 2005 to 2008

Nguyen Van Hung (NTP, Viet Nam)

Diagnostic challenges of active childhood TB in Tanzania. Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre

ESCMID Online Lecture Library. by author

Conflict of Interest Disclosures:

Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review

Tuberculosis Populations at Risk

Tuberculosis outbreak among students in a boarding school

Tuberculosis Update. Topics to be Addressed

Clinical Utility of the QuantiFERON TB-2G Test for Elderly Patients With Active Tuberculosis*

Indeterminate test results of T-SPOT TM.TB performed under routine field conditions

Gerd Gran 1, Jörg Aßmus 2 and Anne Ma Dyrhol-Riise 3,4,5*

(2) 83.3% b/w TST and T-SPOT, (2) 77.4% b/w TST and T-SPOT. 77.7% b/w TST and QFT-GIT. QFT-GIT, 22.2% in T-SPOT. TSPOT vs. TST (> 5 mm) vs.

Making the Diagnosis of Tuberculosis

Transcription:

Southeast Asian J Trop Med Public Health RESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS Benjawan Phetsuksiri 1, Somchai Sangkitporn 1, Janisara Rudeeaneksin 1, Sopa Srisungngam 1, Supranee Bunchoo 1 and Thana Khawcharoenporn 2 1 National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi; 2 Division of Infectious Diseases, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand Abstract. Persons with latent tuberculosis infection (LTBI) are at-risk for developing subsequent active tuberculosis (TB). Screening for LTBI is important, especially in healthcare workers (HCWs) who have increased risk of acquiring TB. The new LTBI screening test, QuantiFERON -TB Gold In-tube Test (QFT-IT) is now available in Thailand. However, data on the rate of positive test and factors associated with test positivity are limited among Thai medical students. We conducted a cross sectional study among clinical-year medical students (fourth to sixth year students) at Thammasat University, Thailand. All students who consented to participate in this study had the QFT-IT and a LTBI risk assessment during June 2014 as part of a health screening program. A total of 204 subjects were included in the program; their median age was 22 years (range: 20-34 years), 52% were female, 94% had a history of Bacillus Calmette-Guérin vaccination. Twenty subjects (10%) had a positive QFT-IT test and were presumed to have LTBI. The median interferon-γ (IFN-γ) level was 0.01 (range: 0-7.37 IU/ml). Independent factors associated with QFT-IT positivity were a history of direct TB contacts [adjusted odds ratio (aor)=3.78; p=0.006), being a sixth year student (aor=2.76; p=0.03) and having a history of working on a ward with active TB patients without having direct TB contacts (aor=2.69; p=0.04]. The QFT-IT was useful in screening our study subjects and should be considered as a screening tool in this population due to the high incidence of QFT-IT positivity. Keywords: QuantiFERON -TB Gold In-tube Test, latent tuberculosis infection, clinical-year, medical students, Thailand Correspondence: Dr Thana Khawcharoenporn, Division of Infectious Diseases, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand. Tel: 66 (0) 81 836 5576; Fax: 66 (0) 2926 9793 E-mail: thanak30@yahoo.com INTRODUCTION Tuberculosis (TB) is a major public health problem in Thailand. The estimated prevalence of TB in the general Thai population is 172 per 100,000 (WHO, 2014). TB 82 Vol 49 No. 1 January 2018

QuantiFERON -TB Gold In-tube Test for LTBI Diagnosis screening and prevention are important to reduce TB incidence, especially in at-risk populations, such as healthcare workers (HCWs) (Khawcharoenporn et al, 2011). The currently available screening tests for latent tuberculosis infection (LTBI) in Thailand are the tuberculin skin test (TST) and the interferon-γ release assays (IGRAs). The TST has limitations, such as false positive results from previous Bacillus Calmette-Guérin (BCG) vaccination and non-tuberculous mycobacterial infections, administrative and interpretative errors and the requirement of two clinic visits (Khawcharoenporn et al, 2011). The IGRAs have gained popularity as a test to diagnose LTBI (CDC, 2010). IGRAs have been demonstrated to be more sensitive and specific than the TST, especially among BCG-vaccinated persons or those from TB-endemic settings (Khawcharoenporn et al, 2011). However, false positive IGRA tests occur in infections due to Mycobacterium kansasii, Mycobacterium szulgai, Mycobacterium marinum and Mycobacterium gordonae (Andersen et al, 2000), due to incorrect blood sample collection, and improper handling of the specimen (Andersen et al, 2007). There is no gold standard test to diagnose LTBI. The interferon (IFN)-γ cut-off level of 0.35 IU/ml for a positive QuantiFERON - TB Gold In-tube Test (Cellestis, Carnegie, Victoria, Australia) (QFT-IT) is derived from studies of active TB cases (CDC, 2010). However, the utility of diagnosing LTBI among Thai medical students using the QFT-IT has not been evaluated before. In addition, data on factors associated with positive QFT-IT among the students is limited. MATERIALS AND METHODS We conducted a cross sectional study among fourth to sixth year medical students at Thammasat University during their clinical clerkship at Thammasat University Hospital (TUH) to determine how many of them had positive QFT-IT and also factors associated with QFT-IT positivity. This study was approved by Faculty of Medicine, Thammasat University Ethics Committee. Inclusion criteria were all the fourth to sixth year medical students participated in the TUH annual health screening program in June 2014. Exclusion criteria were students with prior or current active TB and receipt of TST or IGRA within the prior 12-month period. Data obtained from each subject included demographics, working history, history of BCG vaccination, and LTBI risks. All subjects were screened for active TB by assessing symptoms including fever, coughing more than 2 weeks, night sweat and weight loss of more than 10% within one month and by chest radiograph. All study subjects had a QFT-IT. The test was conducted following the manufacture s guidelines (Mazurek et al, 2010). The IFN-γ level was calculated by subtracting TB antigen response with nil response. The nil response indicates the presence of any residual gamma interferon found in the subject s blood due to an infection with an organism requiring cell mediated immunity/t cell immunity. Direct TB contact was defined as staying in the same closed-ventilation room with active pulmonary TB case without airborne isolation protection. A history of working on a TB ward and the year of study were recorded. All analyses were performed using SPSS, version 15.0 (SPSS, Chicago, IL). Categorical variables were compared using the Pearson s χ 2 or Fisher s exact test when appropriate. Continuous variables were compared using the Mann-Whitney Vol 49 No. 1 January 2018 83

Southeast Asian J Trop Med Public Health Table 1 Characteristics of study subjects by QuantiFERON -TB Gold In-tube Test (QFT-IT) results. Characteristics Number (%) QFT-IT QFT-IT p-value except positive, negative, where noted number (%) number (%) (n = 204) (n =20) (n = 184) Age (years, median, range) 22 (20-34) 23 (20-25) 22 (20-34) 0.32 Female sex 106 (52) 12 (60) 94 (51) 0.45 Study year 0.07 4 85 (42) 7 (35) 78 (42) 5 60 (29) 3 (15) 57 (31) 6 59 (29) 10 (50) 49 (27) History of working on a ward with 118 (58) 16 (80) 102 (55) 0.04 active TB patients without direct TB contact for at least 1 month Working duration on the wards 380 (5-1,825) 730 (10-1,095) 365 (5-1,825) 0.07 (days, median, range) History of a direct TB contacts 28 (14) 7 (35) 21 (11) 0.006 History of BCG vaccination 192 (94) 18 (90) 174 (95) 0.33 Interferon-γ level (IU/ml, median, range) 0.01 (0-7.37) 0.90 (0.39-7.37) 0.01 (0-0.33) <0.001 BCG, Bacillus Calmette-Guérin; LTBI, latent tuberculosis infection; TB, tuberculosis. U test. A p-value <0.05 was considered statistically significant. Adjusted odd ratios (aors) and 95% confidence intervals (CIs) were calculated by multivariable logistic regression analysis to determine factors associated with a positive QFT-IT. RESULTS A total of 204 students were included in this study. The characteristics of the students are summarized in Table 1. Using an IFN-γ cut-off level of 0.35 IU/ml, 20 students (10%) had a positive QFT-IT. When comparing students with positive and negative QFT-IT results, those with a positive result were more-likely to have a history of a direct TB contacts and a history of working on a ward with active TB patients without direct TB contacts (Table 1). On multivariable logistic regression analysis, having a history of a direct TB contacts (aor=3.78; 95% CI: 1.47-9.69; p=0.006), being a sixth year student (aor=2.76; 95% CI: 1.08-7.02; p=0.03) and having a history of working on a ward with active TB patients without direct TB contacts (aor=2.69; 95% CI: 1.05-8.37; p=0.04) were all significantly associated with a positive QFT-IT result. DISCUSSION This is the first study using QFT-IT to diagnose LTBI among clinical-year medical students in Southeast Asia. Ten percent of all subjects had a positive QFT- IT test, which was higher than the rates of positive QFT-IT among healthcare professional students in TB low prevalence countries but comparable to or lower than the rates of positive QFT-IT in TB high 84 Vol 49 No. 1 January 2018

QuantiFERON -TB Gold In-tube Test for LTBI Diagnosis Table 2 Summary of studies using the QuantiFERON-TB (QFT) to screen for latent tuberculosis infection among healthcare professional students. Reference Country TB Study Sample Type of Study QFT Factors associated incidence type size QFT population positivity with QFT (cases/100,000) a rate positivity Pai et al, 2006 India 217 Prospective 216 QFT-IT Medical and 18% No data cohort nursing students Zwerling et al, 2013 India 217 Prospective cohort 226 QFT-IT Medical and 28% Days spent working nursing students on medical wards Eum et al, 2008 South Korea 80 Cross sectional 48 QFT-IT BCG-vaccinated 10% No data medical students Dagnew et al, 2012 Ethiopia 192 Cross sectional 107 QFT-IT Male medical and 44% Older age, Khat b paramedic students consumption Jung et al, 2012 South Korea 80 Cross sectional 153 QFT-IT Medical students 5% No data Our study Thailand 172 Prospective cohort 204 QFT-IT Medical students 10% History of direct TB contacts, higher study year, history of working on a ward with active TB patients without direct TB contacts Veeser et al, 2007 United States 3 Retrospective 54 QFT-IT Students of University 15% No data chart review Health Services Hotta et al, 2007 Japan 17 Cross sectional 207 QFT Medical, nursing and 1% No data dental students Schablon et al, 2013 Germany 8 Prospective cohort 194 QFT-IT Healthcare professional 2% No data students Lamberti et al, 2015 Italy 6 Cross sectional 1,577 QFT-IT Nursing students 0.1% c No data Lamberti et al, 2014 Italy 6 Cross sectional 3,374 QFT-IT Healthcare professional 1% c Older age, higher students study year Lamberti et al, 2017 Italy 6 Cross sectional 281 QFT-IT Undergraduate and 3% c Higher study year d postgraduate dental students a Based on the World Health Organization tuberculosis country profiles (WHO, 2014). b A plant named Catha edulis. c Most participants were tested positive for tuberculin skin test first, then had QFT. Some participants were tested by QFT as the first test. d This factor was associated with tuberculin skin test and/or QFT positivity. BCG, Bacillus Calmette-Guérin; QFT, QuantiFERON -TB Test; QFT-IT, QuantiFERON -TB Gold In-tube Test; TB, tuberculosis. Vol 49 No. 1 January 2018 85

Southeast Asian J Trop Med Public Health prevalence countries (Table 2). The risk factors associated with a positive QFT-IT in this study were history of a direct TB contacts, being a sixth year student and having a history of working on a ward with active TB patients without direct TB contacts. Other studies reported that older age, higher study year and number of days spent working on medical wards were risk factors associated with a positive QFT-IT among healthcare professional students (Dagnew et al, 2012; Zwerling et al, 2013; Lamberti et al, 2014; Lamberti et al, 2017). These reported factors were consistent with our study s results which suggest that infection control measures need to be strictly implemented not just for the active TB patients but the students need to be educated in preventive methods and given appropriate protection. Limitations of this study include the small sample size of the included subjects and the single site study. The study results may not be generalizable to other medical students in Thailand. In conclusion, the QFT-IT positivity rate among our study subjects was high. The risk factors associated with QFT-IT positivity were history of a direct TB contacts, being a sixth year student and having a history of working on a ward with active TB patients without direct TB contacts. The QFT-IT was useful in screening our study subjects and should be considered as a screening tool in this population due to the high incidence of QFT-IT positivity. ACKNOWLEDGEMENTS This study was partially supported by funding from National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Thailand. REFERENCES Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-104. Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med 2007; 13: 175-82. Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection United States, 2010. MMWR Recomm Rep 2010; 59: 1-25. Dagnew AF, Hussein J, Abebe M, et al. Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth. BMC Res Notes 2012; 5: 415. Eum SY, Lee YJ, Kwak HK, et al. Evaluation of the diagnostic utility of a whole-blood interferon-gamma assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calmette-Guerin (BCG)-vaccinated individuals. Diagn Microbiol Infect Dis 2008; 61: 181-6. Hotta K, Ogura T, Nishii K, et al. Whole blood interferon-gamma assay for baseline tuberculosis screening among Japanese healthcare students. PLOS One 2007; 2: e803. Jung DH, Jo KW, Shim TS. Prevalence of latent tuberculosis infection among medical students in South Korea. Tuberc Respir Dis (Seoul) 2012; 73: 219-23. Khawcharoenporn T, Apisarnthanarak A, Sungkanuparph S, Woeltje KF, Fraser VJ. Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas. Int J Tuberc Lung Dis 2011; 15: 14-23. Lamberti M, Muoio M, Monaco MG, et al. Prevalence of latent tuberculosis infection and associated risk factors among 3,374 healthcare students in Italy. J Occup Med Toxicol 2014; 9: 34. Lamberti M, Uccello R, Monaco MG, et al. Prev- 86 Vol 49 No. 1 January 2018

QuantiFERON -TB Gold In-tube Test for LTBI Diagnosis alence of latent tuberculosis infection and associated risk factors among 1557 nursing students in a context of low endemicity. Open Nurs J 2015; 9: 10-4. Lamberti M, Muoio MR, Westermann C, et al. Prevalence and associated risk factors of latent tuberculosis infection among undergraduate and postgraduate dental students: a retrospective study. Arch Environ Occup Health 2017; 72: 99-105. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010; 59: 1-25. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006; 174: 349-55. Schablon A, Peters C, Diel R, et al. Serial IGRA testing of trainees in the healthcare sector in a country with low incidence for tuberculosis - a prospective cohort study. GMS Hyg Infect Control 2013; 8: Doc17. doi:10.3205/dgkh000217. Veeser PI, Smith PK, Handy B, Martin SR. Tuberculosis screening on a health science campus: use of QuantiFERON-TB Gold Test for students and employees. J Am Coll Health 2007; 56: 175-80. World Health Organization (WHO). Tuberculosis country profiles. Geneva: WHO, 2014. [Cited 2017 May 1]. Available from: http:// www.who.int/tb/country/data/profiles/en/ Zwerling A, Joshi R, Kalantri SP, et al. Trajectories of tuberculosis-specific interferongamma release assay responses among medical and nursing students in rural India. J Epidemiol Glob Health 2013; 3: 105-17. Vol 49 No. 1 January 2018 87